Literature DB >> 21046359

Metformin in type 1 diabetes reduces insulin requirements without significantly improving glycaemic control. Reply to Schatz H [letter].

S Vella, L Buetow, P Royle, S Livingstone, J R Petrie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21046359     DOI： 10.1007/s00125-010-1953-z

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  6 in total

Review 1.  Assessing ethics of trials in systematic reviews.

Authors:  Michael A Weingarten; Mical Paul; Leonard Leibovici
Journal:  BMJ       Date:  2004-04-24

2.  Metformin in type 1 diabetes reduces insulin requirements without significantly improving glycaemic control.

Authors:  H Schatz
Journal:  Diabetologia       Date:  2010-07-09       Impact factor: 10.122

3.  CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

Authors:  David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman
Journal:  BMJ       Date:  2010-03-23

4.  Reporting ethics committee approval and patient consent by study design in five general medical journals.

Authors:  S Schroter; R Plowman; A Hutchings; A Gonzalez
Journal:  J Med Ethics       Date:  2006-12       Impact factor: 2.903

5.  Studies on juvenile--type diabetes in children. Assessment of control under treatment with constant and variable doses of insulin with or without addition of biguanides.

Authors:  H Schatz; G Winkler; E M Jonatha; E F Pfeiffer
Journal:  Diabete Metab       Date:  1975-12

Review 6.  The use of metformin in type 1 diabetes: a systematic review of efficacy.

Authors:  S Vella; L Buetow; P Royle; S Livingstone; H M Colhoun; J R Petrie
Journal:  Diabetologia       Date:  2010-01-08       Impact factor: 10.122
  6 in total
  5 in total

1.  Lipoprotein subfraction cholesterol distribution is more atherogenic in insulin resistant adolescents with type 1 diabetes.

Authors:  Melanie Cree-Green; David M Maahs; Annie Ferland; John E Hokanson; Hong Wang; Laura Pyle; Gregory L Kinney; Martina King; Robert H Eckel; Kristen J Nadeau
Journal:  Pediatr Diabetes       Date:  2015-06-17       Impact factor: 4.866

2.  Metformin: Midlife maturity, maiden charm.

Authors:  Sanjay Kalra; Puneet Dhamija; Ashok K Das
Journal:  Indian J Endocrinol Metab       Date:  2012-11

3.  The Effect of Metformin as an Adjunct Therapy in Adolescents with Type 1 Diabetes.

Authors:  Aria Setoodeh; Abdollah Didban; Ali Rabbani; Azadeh Sayarifard; Farzaneh Abbasi; Fatemeh Sayarifard; Fatemeh Hoseinzade
Journal:  J Clin Diagn Res       Date:  2017-04-01

4.  Ovarian morphology and prevalence of polycystic ovary syndrome in Japanese women with type 1 diabetes mellitus.

Authors:  Arina Miyoshi; So Nagai; Masamitsu Takeda; Takuma Kondo; Hiroshi Nomoto; Hiraku Kameda; Amiko Hirai; Kyuyong Cho; Kimihiko Kimachi; Chikara Shimizu; Tatsuya Atsumi; Hideaki Miyoshi
Journal:  J Diabetes Investig       Date:  2013-02-13       Impact factor: 4.232

5.  A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Metformin Therapy in Overweight/Obese Youth with Type 1 Diabetes.

Authors:  Benjamin Udoka Nwosu; Louise Maranda; Karen Cullen; Lisa Greenman; Jody Fleshman; Nancy McShea; Bruce A Barton; Mary M Lee
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.